Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Chirocaine
Active Ingredient: Levobupivacaine hydrochloride 2.816mg/mL equivalent to 2.5mg/ml levobupivacaine
Dosage Form: Solution for injection
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Antigen Pharmaceuticals Limited, Roscrea, Co. Tipperary, Eire
Product: Chirocaine
Active Ingredient: Levobupivacaine hydrochloride 5.633mg/mL equivalent to 5mg/mL levobupivacaine
Dosage Form: Solution for injection
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Antigen Pharmaceuticals Limited, Roscrea, Co. Tipperary, Eire
Product: Chirocaine
Active Ingredient: Levobupivacaine hydrochloride 8.449mg/mL equivalent to 7.5mg/mL levobupivacaine
Dosage Form: Solution for injection
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Antigen Pharmaceuticals Limited, Roscrea, Co. Tipperary, Eire
Product: Zanidip
Active Ingredient: Lercanidipine hydrochloride 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Muir Hutchison Limited
Manufacturer: Recordati Industria Chimica e Farmaceutica SpA, Milan, Italy
Dated this 13th day of March 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).